#therapeutics — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #therapeutics, aggregated by home.social.
-
31-Jul-2026
Two deadly flowers have big #medical potential
Two #plants that cause #neurotoxicity and paralysis in the tiniest doses are also known to counter pain, malaria, cancer and pests. For the first time, researchers discovered a way to recreate these powerful compounds in the lab, helping lead the way to improved, naturally-sourced #therapeutics. -
31-Jul-2026
Two deadly flowers have big #medical potential
Two #plants that cause #neurotoxicity and paralysis in the tiniest doses are also known to counter pain, malaria, cancer and pests. For the first time, researchers discovered a way to recreate these powerful compounds in the lab, helping lead the way to improved, naturally-sourced #therapeutics. -
[Comment] Beyond #vaccines: closing the critical #gap in #diagnostics and #therapeutics for #outbreak response https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00378-6/fulltext?rss=yes
''... the #Bundibugyo virus outbreak serves as a reminder that diagnostics and treatments are equally essential components of an effective response.''
-
[Comment] Beyond #vaccines: closing the critical #gap in #diagnostics and #therapeutics for #outbreak response https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00378-6/fulltext?rss=yes
''... the #Bundibugyo virus outbreak serves as a reminder that diagnostics and treatments are equally essential components of an effective response.''
-
EPHX2 modulates intestinal barrier repair in UC.
🔬 EPHX2 is downregulated in inflamed colonic cells.
🧫 Its deficiency hinders mucosal healing.
🔍 Highlights EPHX2 as a UC therapeutic target.https://tnyp.me/A0oEsYFE/m #UlcerativeColitis #EPHX2 #Genetics #Therapeutics #Research
-
EPHX2 modulates intestinal barrier repair in UC.
🔬 EPHX2 is downregulated in inflamed colonic cells.
🧫 Its deficiency hinders mucosal healing.
🔍 Highlights EPHX2 as a UC therapeutic target.https://tnyp.me/A0oEsYFE/m #UlcerativeColitis #EPHX2 #Genetics #Therapeutics #Research
-
🔥 TRENDING
📢 Crispr Therapeutics: 2,56 Milliarden Dollar Liquidität - AD HOC NEWS
#Ia #Crispr #Therapeutics #Milliarden #GlobalFeed #News #DE
*Automatisch gepostet von Global Feed Bot*
-
🔥 TRENDING
📢 CRISPR Therapeutics Aktie - boerse.de
#Crispr #Therapeutics #Aktie #GlobalFeed #News #DE
*Automatisch gepostet von Global Feed Bot*
-
🔥 TRENDING
📢 CRISPR Therapeutics-Aktie unter 200-Tage-Linie - boerse.de
#Crispr #Therapeutics-aktie #GlobalFeed #News #DE
*Automatisch gepostet von Global Feed Bot*
-
🔥 TRENDING
📢 CRISPR Therapeutics-Aktie über 200-Tage-Linie - boerse.de
#Crispr #Therapeutics-aktie #GlobalFeed #News #DE
*Automatisch gepostet von Global Feed Bot*
-
creates semantic nodes and clusters #TECHNOCRACY advanced-search.aepiot.ro/advanced-sea... #CAMERON #PRIZE #FOR #THERAPEUTICS OF #THE #UNIVERSITY OF #EDINBURGH advanced-search.aepiot.com/advanced-sea... AÉPIOT: INDEPENDENT SEMANTIC WEB 4.0 INFRASTRUCTURE (EST. 2009): aepiot.com
MultiSearch Tag Explorer -
Exosomes containing signaling molecules derived from wild Scandinavian flatworms can significantly accelerate tissue repair and wound healing in human skin models.
#ChemicalBiology #RegenerativeMedicine #MolecularBiology #Therapeutics #sflorg
https://www.sflorg.com/2026/04/bio04282601.html -
Exosomes containing signaling molecules derived from wild Scandinavian flatworms can significantly accelerate tissue repair and wound healing in human skin models.
#ChemicalBiology #RegenerativeMedicine #MolecularBiology #Therapeutics #sflorg
https://www.sflorg.com/2026/04/bio04282601.html -
Sarepta Therapeutics announces commercial launch of ELEVIDYS in Japan for DMD treatment
Sarepta Therapeutics announces commercial launch of ELEVIDYS in Japan for DMD treatment February 25, 2026 | Wednesday | News Company is eligible to receive a $40 million milestone payment upon first commercial sale in Ja…
#Japan #JP #JapanNews #DMD #genetherapy #launch #news #Therapeutics
https://www.alojapan.com/1457342/sarepta-therapeutics-announces-commercial-launch-of-elevidys-in-japan-for-dmd-treatment/ -
https://www.alojapan.com/1457342/sarepta-therapeutics-announces-commercial-launch-of-elevidys-in-japan-for-dmd-treatment/ Sarepta Therapeutics announces commercial launch of ELEVIDYS in Japan for DMD treatment #DMD #GeneTherapy #Japan #JapanNews #launch #news #Therapeutics Sarepta Therapeutics announces commercial launch of ELEVIDYS in Japan for DMD treatment February 25, 2026 | Wednesday | News Company is eligible to receive a $40 million milestone payment upon first commercial sale in Japan US-based Sarepta Therapeutics, Inc. has announced the commercial launc
-
Single Dose of DMT Rapidly Reduces Symptoms of Major Depression
Small Phase IIa study [34 subjects] but some interesting points
"intravenous DMT has a half-life of around five minute"
and
"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive symptoms, sustained up to three months,"https://www.sciencealert.com/single-dose-of-dmt-rapidly-reduces-symptoms-of-major-depression
Primary article: https://www.nature.com/articles/s41591-025-04154-z
-
Single Dose of DMT Rapidly Reduces Symptoms of Major Depression
Small Phase IIa study [34 subjects] but some interesting points
"intravenous DMT has a half-life of around five minute"
and
"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive symptoms, sustained up to three months,"https://www.sciencealert.com/single-dose-of-dmt-rapidly-reduces-symptoms-of-major-depression
Primary article: https://www.nature.com/articles/s41591-025-04154-z
-
When the immune system detects a protein from a pathogen,
it’s supposed to dispatch killer T cells to eliminate the invader.Some cancers can interfere with this process by hijacking the checkpoint proteins that keep our immune system from revving out of control
and using them to turn T cells off.Starting in the mid-1990s, several research teams found success by treating mice with #checkpoint #inhibitors,
-- then a new class of drugs designed to keep tumor cells from concealing their identity and signaling, effectively, “nothing to see here.”Thirty years on, checkpoint inhibitors have become a transformative tool in cancer treatment, especially for melanoma.
The research that went into developing checkpoint inhibitors showed conclusively that immune cells detect cancer much in the same way they identify other pathogens:
through differences in protein structure determined by DNA
—a crucial insight.But as revolutionary as checkpoint inhibitors have been for immunotherapy, they don’t work for everyone
—far from it.Some 80 percent of patients do not respond to this class of drugs.
Researchers are still trying to understand all the mechanisms that play a role in determining who does respond,
but one key factor is whether the immune system is able to recognize tumor cells on the basis of their mutations.This is where mRNA vaccines come in.
#Jason #Luke, a melanoma researcher who now serves as chief medical officer of mRNA-medicine start-up #Strand #Therapeutics,
helped to design several ongoing clinical trials of mRNA vaccines for cancer.He explains that both checkpoint inhibitors and mRNA vaccines build on our deep evolutionary adaptation for fighting pathogens
by identifying the proteins they shed in our bodies.But checkpoint inhibitors are effective only if the patient’s immune system recognizes the cancer as a threat.
In contrast, mRNA vaccines have the potential to work even in patients whose cancers haven’t spurred much immune response.
The trick, Luke says, is using computational tools to decipher which of a given tumor’s mutations are most likely to be found by the immune system.
-
When the immune system detects a protein from a pathogen,
it’s supposed to dispatch killer T cells to eliminate the invader.Some cancers can interfere with this process by hijacking the checkpoint proteins that keep our immune system from revving out of control
and using them to turn T cells off.Starting in the mid-1990s, several research teams found success by treating mice with #checkpoint #inhibitors,
-- then a new class of drugs designed to keep tumor cells from concealing their identity and signaling, effectively, “nothing to see here.”Thirty years on, checkpoint inhibitors have become a transformative tool in cancer treatment, especially for melanoma.
The research that went into developing checkpoint inhibitors showed conclusively that immune cells detect cancer much in the same way they identify other pathogens:
through differences in protein structure determined by DNA
—a crucial insight.But as revolutionary as checkpoint inhibitors have been for immunotherapy, they don’t work for everyone
—far from it.Some 80 percent of patients do not respond to this class of drugs.
Researchers are still trying to understand all the mechanisms that play a role in determining who does respond,
but one key factor is whether the immune system is able to recognize tumor cells on the basis of their mutations.This is where mRNA vaccines come in.
#Jason #Luke, a melanoma researcher who now serves as chief medical officer of mRNA-medicine start-up #Strand #Therapeutics,
helped to design several ongoing clinical trials of mRNA vaccines for cancer.He explains that both checkpoint inhibitors and mRNA vaccines build on our deep evolutionary adaptation for fighting pathogens
by identifying the proteins they shed in our bodies.But checkpoint inhibitors are effective only if the patient’s immune system recognizes the cancer as a threat.
In contrast, mRNA vaccines have the potential to work even in patients whose cancers haven’t spurred much immune response.
The trick, Luke says, is using computational tools to decipher which of a given tumor’s mutations are most likely to be found by the immune system.
-
RE: https://mastodon.social/@HafizHusnain/115328490796649616
This review connects molecular biology and clinical neuroscience, showing how #miRNAs could transform how we diagnose and treat neurodegenerative diseases.
#Neuroscience #Neurodegeneration #Biomarkers #miRNA #MolecularBiology #Alzheimers #Parkinsons #ALS #Huntingtons #biosensors #NGS #Diagnostics #Therapeutics #AcademicMastodon #OpenScience #springernature
-
Non-neutralizing #antibodies to #influenza A #matrix-protein-2-ectodomain are broadly effective #therapeutics and resistant to viral escape mutations, https://etidiohnew.blogspot.com/2025/09/non-neutralizing-antibodies-to.html
-
Non-neutralizing #antibodies to #influenza A #matrix-protein-2-ectodomain are broadly effective #therapeutics and resistant to viral escape mutations, https://etidiohnew.blogspot.com/2025/09/non-neutralizing-antibodies-to.html
-
Study uncovers how teeth hold key clues to childhood craniofacial disorders
Teeth may seem like static fixtures, but a new collaboration between engineers and clinicians is proving just how…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Genetics #children #Craniofacial #Dentin #Genetic #hospital #medicine #Nanotechnology #pediatrics #Research #Science #Spectroscopy #Teeth #Therapeutics #ToothEnamel
https://www.newsbeep.com/us/23855/ -
EthanRusso.org is the personal website of #EthanRusso, MD, a #neurologist and medical #researcher.
I’m proud to announce a new course offering with our partners at MM411, “Certificate of Advanced #Cannabis #Pharmacology & #Therapeutics”. This course is for practitioners and professionals who want to provide evidence-based care and support to patients seeking alternatives to conventional pharmaceutical therapies.
-
Mediterranean plants show promise for cardiovascular disease treatment
A study initiated from a final degree project at the Universitat Autònoma de Barce…
#dining #cooking #diet #food #mediterranean #MediterraneanDiet #MediterraneanFood #atherosclerosis #drugs #Efficacy #Garlic #Mediterranean #Mortality #Pharmacology #Pharmacy #Preclinical #Research #Saffron #Therapeutics #toxicology
https://www.diningandcooking.com/2139856/mediterranean-plants-show-promise-for-cardiovascular-disease-treatment/ -
From #MedicalCannabis
#Explore the Dr. #EthanRusso Certificate of
#AdvancedCannabis #Pharmacology & #Therapeutics
Want to provide evidence-based care for patients suffering from chronic pain, cancer treatment side effects, and other conditions?
https://discover.mm411.com/?utm_source=credo&medium=ethanrussowebsite
#Hanfgeschichten #Zukunft #Medizin #Zeitgeschichte
#SPD #FDP #noAfD #CSU #CDU #DIELINKE #Grüne #Christen #Kirche #Gesundheitsschutz & #klimaschutz mit #Cannabis ist auch #Menschenschutz #BIGGERthanUS -
AI Helps Find a Cause of Alzheimer's Disease and Identify Therapeutic Candidate
#HackerNews #AI #Research #Therapeutics #HealthInnovation #Neuroscience
-
AI Helps Find a Cause of Alzheimer's Disease and Identify Therapeutic Candidate
#HackerNews #AI #Research #Therapeutics #HealthInnovation #Neuroscience
-
Explore TxGemma, Google's open models designed to boost therapeutic development by predicting therapeutic properties. Potentially cuts time & costs associated with traditional methods. #AI #Therapeutics
-
Trippy #Science Unravels the Mystery of #Psychedelics’ #Antianxiety Effects
Researchers mimic the antianxiety effects of psychedelics by identifying and activating specific #brain regions in an important step towards developing #therapeutics that do not cause #hallucinations.
-
Trippy #Science Unravels the Mystery of #Psychedelics’ #Antianxiety Effects
Researchers mimic the antianxiety effects of psychedelics by identifying and activating specific #brain regions in an important step towards developing #therapeutics that do not cause #hallucinations.
-
DATE: September 03, 2024 at 07:00AM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
Microbiotica entering clinic with live bacterial therapeutics
#medtech @MicrobioticaLtd #therapeutics
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
-
DATE: September 03, 2024 at 07:00AM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
Microbiotica entering clinic with live bacterial therapeutics
#medtech @MicrobioticaLtd #therapeutics
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
-
DATE: August 30, 2024 at 03:57PM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
Microbiotica entering clinic with live bacterial therapeutics
#medtech @MicrobioticaLtd #therapeutics
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
-
DATE: August 30, 2024 at 03:57PM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
Microbiotica entering clinic with live bacterial therapeutics
#medtech @MicrobioticaLtd #therapeutics
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
-
"We developed a method of #phage-assisted continuous evolution we call IntePACE..to systematically improve activity of PhiC31 & Bxb1 serine integrases..hyperactive mutants were generated..resulting in integration of a multi-gene cargo at rates as high as 80%..Hyperactive integrases inserted a 15.7 kb therapeutic #DNA cargo..This #technology could accelerate #gene delivery #therapeutics & our directed evolution strategy can easily be adapted to improve novel #integrases"
https://academic.oup.com/nar/article/52/14/e64/7702507?login=false
-
"We developed a method of #phage-assisted continuous evolution we call IntePACE..to systematically improve activity of PhiC31 & Bxb1 serine integrases..hyperactive mutants were generated..resulting in integration of a multi-gene cargo at rates as high as 80%..Hyperactive integrases inserted a 15.7 kb therapeutic #DNA cargo..This #technology could accelerate #gene delivery #therapeutics & our directed evolution strategy can easily be adapted to improve novel #integrases"
https://academic.oup.com/nar/article/52/14/e64/7702507?login=false
-
Psilocybin desynchronizes the human brain
https://www.nature.com/articles/s41586-024-07624-5
#Psilocybin #Neuroplasticity #BrainConnectivity #Psychedelics #Serotonin #MentalHealth #Therapeutics #fMRI #Neuroscience #FunctionalMapping #Hippocampus #ClinicalTrials #Depression #Addiction #Anxiety #Synaptogenesis #Glutamate #BrainResearch #Cortex #Subcortex #EgoDissolution #SpaceTimePerception #Neurobiology #TherapeuticMechanisms #BrainNetworks #PrecisionMapping #BrainChanges #PsychedelicResearch #BrainFunction
-
Psilocybin desynchronizes the human brain
https://www.nature.com/articles/s41586-024-07624-5
#Psilocybin #Neuroplasticity #BrainConnectivity #Psychedelics #Serotonin #MentalHealth #Therapeutics #fMRI #Neuroscience #FunctionalMapping #Hippocampus #ClinicalTrials #Depression #Addiction #Anxiety #Synaptogenesis #Glutamate #BrainResearch #Cortex #Subcortex #EgoDissolution #SpaceTimePerception #Neurobiology #TherapeuticMechanisms #BrainNetworks #PrecisionMapping #BrainChanges #PsychedelicResearch #BrainFunction
-
Simone Schuerle is an Assistant Professor at ETH Zürich, where she leads the Responsive Biomedical System Lab. With her team, she develops diagnostic and therapeutic systems at the nano- and microscale with the aim of tackling a range of challenging problems in medicine.
Listen to our chat here: https://robottalk.org/2024/06/14/episode-89-simone-schuerle/
-
Simone Schuerle is an Assistant Professor at ETH Zürich, where she leads the Responsive Biomedical System Lab. With her team, she develops diagnostic and therapeutic systems at the nano- and microscale with the aim of tackling a range of challenging problems in medicine.
Listen to our chat here: https://robottalk.org/2024/06/14/episode-89-simone-schuerle/
-
📢 New Episode Alert!
This week, @claireasher chats to Prof. Simone Schuerle from ETH Zürich all about microrobots, medicine and science.
Listen now: http://robottalk.org/2024/06/14/episode-89-simone-schuerle/
-
📢 New Episode Alert!
This week, @claireasher chats to Prof. Simone Schuerle from ETH Zürich all about microrobots, medicine and science.
Listen now: http://robottalk.org/2024/06/14/episode-89-simone-schuerle/
-
🧬🗝️ Have you ever heard that #RNA might be the key to fighting fungal infections? If not, we highly suggest to ...
#MeetOurScientist Matthew in the video, and discover why taking a closer look at RNA biology is paramount in understanding and fighting human pathogenic #fungi! 🔬
#RNABiology #RNAResearch #Science #Diagnostics #Therapeutics #LeibnizHKI
👉 Go to the video: https://youtu.be/u1imp451U10?si=GTGRclarjAZww-1w
-
In this new podcast episode, Dr. Lin Tian discusses her research creating molecular tools to study neural circuits, understand neurological disorders, and develop better therapeutics. She also provides insight into her career path, recent successes, advice, and more.
https://www.peoplebehindthescience.com/dr-lin-tian/
#neuroscience #neuro #biology #molecularbiology #science #Research #therapeutics #sciencecommunication #scicomm #podcast #podcasts #womeninscience #WomenInSTEM #STEM
-
In this new podcast episode, Dr. Lin Tian discusses her research creating molecular tools to study neural circuits, understand neurological disorders, and develop better therapeutics. She also provides insight into her career path, recent successes, advice, and more.
https://www.peoplebehindthescience.com/dr-lin-tian/
#neuroscience #neuro #biology #molecularbiology #science #Research #therapeutics #sciencecommunication #scicomm #podcast #podcasts #womeninscience #WomenInSTEM #STEM
-
Belgium’s university-industry collaboration model could accelerate EU’s advanced therapeutics [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/belgiums-university-industry-collaboration-model-could-accelerate-eus-advanced-therapeutics/?utm_source=dlvr.it&utm_medium=mastodon #ATMPs #Belgium #EUPharmaPackage #promoted #therapeutics